[Skip to Content]
[Skip to Content Landing]
Views 401
Citations 0
February 27, 2013

Prognostic Assay in Small, Node-Negative Non–Small Cell Lung Cancer

JAMA. 2013;309(8):769-770. doi:10.1001/jama.2012.211724

To the Editor: Dr Kratz and colleagues1 suggested that the use of a new molecular assay could affect prognosis and therapeutic strategy in patients with small, node-negative non–small cell lung cancer (NSCLC). This assay has been previously validated by the same authors in an international population with nonsquamous NSCLC.2 Some points about the results need to be considered.

First Page Preview View Large
First page PDF preview
First page PDF preview